SIRIO to Launch PureOrganix Range of Gummies at Vitafoods Europe

SIRIO to Launch PureOrganix Range of Gummies at Vitafoods Europe

By, Admin 3 May 2024

Overview

SIRIO Pharma (SIRIO), the global nutraceutical contract development and manufacturing organization (CDMO), is set to debut a new range of organic formulations tailored to European consumers at Vitafoods Europe being held from May 14-16. The newly introduced PureOrganix concepts are formulated to meet the stringent EU-Organic certification criteria and include three ready-to-market gummies and one softgel.

Global Market

Demand for organic formulations is growing rapidly, with the global herbal extracts market expected to exceed $8 billion in 2030, up from just $5 billion in 2020.

Opportunities by PureOrganix 

  • The PureOrganix range offers European brands the opportunity to quickly bring fully tested and optimized formulations with trending ingredient combinations to market. 
  • The products target three health areas: a women’s health gummy and softgel for support during PMS and menopause with evening primrose oil; a metabolic health gummy with apple cider vinegar, and a heart health gummy with flaxseed oil that ‘contributes to the maintenance of normal blood cholesterol levels.

EPO Gummies

  • Sirio's organic evening primrose oil (EPO) gummy targets PMS and menopause symptoms. It is pectin-based, delivering 250mg of EPO (GLA 10%) with a delightful mixed berry flavour. 
  • Additionally, the PureOrganix softgel contains 500mg of EPO, supplemented by an extra 45mg of gamma linoleic acid (GLA). 
  • Significantly, for brands looking for an experienced partner, the company’s German GMP facility – where the softgels are produced – has held the organic certification since 2010.

Area of growth: Nutraceuticals

  • Another growth area for nutraceuticals, particularly those with natural actives, is for products that aim to address metabolism concerns and weight management control. 
  • In response, Sirio has created a ready-to-market organic gummy with 500mg of Apple Cider Vinegar, an ingredient well-known for metabolic health benefits and weight loss support.

PureOrganix flaxseed Oil Gummy

  • A final star concept, the PureOrganix flaxseed oil gummy, features 120mg of flaxseed oil, which is rich in alpha-linolenic acid (ALA), a nutrient that has an approved EFSA claim for helping ‘maintain normal blood cholesterol levels’. 
  • The gummy, made with pectin and lemon-flavoured, offers a delicious and convenient way to support cardiovascular health.

These latest products follow on from last month’s launch of a ‘women’s health platform’ that will also be featured at Vitafoods Europe: it showcases 20 ready-to-formulate concepts spanning a woman’s entire life journey, from pre-puberty to post-menopause, with concrete options for holistic health.

Words from Sirio Europe & Americas

Sara Lesina, general manager Sirio Europe & Americas, commented: “We meticulously designed the new organic range so our customers could quickly introduce first-in-class products with organic ingredients for European markets. Thanks to our 200+ strong global R&D team, we have been able to create consumer-friendly dosages for some of the most in demand botanical ingredients, like EPO or ACV. We see a big opportunity for brands to differentiate in the EU market with organic nutraceutical gummies and softgels, especially for those that come with proven health benefits and formulary excellence. This is why leading brands consistently turn to Sirio to research and develop their next breakthrough nutraceuticals."

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!